Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Specimen Handling × Clear all

Sponsor

Conditions

Neoplasm Metastasis 7 Multiple Myeloma 7 Lung Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Neuroblastoma 5 Melanoma 5 Fallopian Tube Neoplasms 5 Burkitt Lymphoma 5 Breast Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Non-Small-Cell Lung 4 Wilms Tumor 3 Triple Negative Breast Neoplasms 3 Rhabdoid Tumor 3 Ovarian Neoplasms 3 Osteosarcoma 3 Neuroendocrine Tumors 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Malignant Solid Neoplasm 3 Leukemia, Biphenotypic, Acute 3 Histiocytosis, Langerhans-Cell 3 Hepatoblastoma 3 Hematologic Neoplasms 3 Glioma 3 Ependymoma 3 Central Nervous System Neoplasms 3 Small Cell Lung Carcinoma 2

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡